The IPO of Senores Pharmaceuticals saw a strong investor response, with total subscriptions exceeding 93.41 times by the close.
We use cookies to ensure you get the best experience on our website. Cookies also help us deliver personalized advertisements through Google Ads.
Do you consent to the use of these cookies?